Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Respirology (Carlton, Vic.)|June 16, 2005
Advances in the diagnosis, evaluation, and management of malignant pleural mesotheliomaDaniel H Sterman, Steven M Albelda
Carcinogenesis|March 20, 2012
Tumor-associated neutrophils: friend or foe?Zvi G Fridlender, Steven M Albelda
Molecular Therapy Oncolytics|May 11, 2016
Chimeric antigen receptor T-cell therapy for solid tumorsKheng Newick, Edmund Moon, Steven M Albelda
Current Treatment Options in Oncology|April 27, 2011
Gene therapy for mesotheliomaAnil Vachani, Edmund Moon, Steven M Albelda
Expert Opinion on Biological Therapy|November 12, 2020
Mesothelin-targeted CAR-T cell therapy for solid tumorsAstero Klampatsa, Vivian Dimou, Steven M Albelda
Trends in Cancer|July 19, 2017
Mouse versus Human Neutrophils in Cancer: A Major Knowledge GapEvgeniy B Eruslanov, Sunil Singhal, Steven M Albelda
Cell Research|July 4, 2015
Promoting metastasis: neutrophils and T cells join forcesZvi G Fridlender, Steven M Albelda, Zvi Granot
Clinics in Chest Medicine|March 21, 2002
Gene therapy for lung neoplasmsSteven M Albelda, Rainer Wiewrodt, Daniel H Sterman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Cytokine gene therapy for malignant pleural mesotheliomaAnil Vachani, Daniel H Sterman, Steven M Albelda
Annals of the American Thoracic Society|June 15, 2017
The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune SystemEdmund K Moon, Corey J Langer, Steven M Albelda
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Respirology (Carlton, Vic.)|June 16, 2005
Advances in the diagnosis, evaluation, and management of malignant pleural mesotheliomaDaniel H Sterman, Steven M Albelda
Carcinogenesis|March 20, 2012
Tumor-associated neutrophils: friend or foe?Zvi G Fridlender, Steven M Albelda
Molecular Therapy Oncolytics|May 11, 2016
Chimeric antigen receptor T-cell therapy for solid tumorsKheng Newick, Edmund Moon, Steven M Albelda
Current Treatment Options in Oncology|April 27, 2011
Gene therapy for mesotheliomaAnil Vachani, Edmund Moon, Steven M Albelda
Expert Opinion on Biological Therapy|November 12, 2020
Mesothelin-targeted CAR-T cell therapy for solid tumorsAstero Klampatsa, Vivian Dimou, Steven M Albelda
Trends in Cancer|July 19, 2017
Mouse versus Human Neutrophils in Cancer: A Major Knowledge GapEvgeniy B Eruslanov, Sunil Singhal, Steven M Albelda
Cell Research|July 4, 2015
Promoting metastasis: neutrophils and T cells join forcesZvi G Fridlender, Steven M Albelda, Zvi Granot
Clinics in Chest Medicine|March 21, 2002
Gene therapy for lung neoplasmsSteven M Albelda, Rainer Wiewrodt, Daniel H Sterman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Cytokine gene therapy for malignant pleural mesotheliomaAnil Vachani, Daniel H Sterman, Steven M Albelda
Annals of the American Thoracic Society|June 15, 2017
The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune SystemEdmund K Moon, Corey J Langer, Steven M Albelda
Pageof 20